Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

Most cited article(s)

  • Open Access
    Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
    Katrine Wickstroem, Urs B. Hagemann, Véronique Cruciani, Antje M. Wengner, Alexander Kristian, Christine Ellingsen, Gerhard Siemeister, Roger M. Bjerke, Jenny Karlsson, Olav B. Ryan, Lars Linden, Dominik Mumberg, Karl Ziegelbauer and Alan S. Cuthbertson
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1293-1300; DOI: https://doi.org/10.2967/jnumed.118.223701
  • You have access
    PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
    Gaochao Lv, Xiaorong Sun, Ling Qiu, Yan Sun, Ke Li, Qingzhu Liu, Qi Zhao, Songbing Qin and Jianguo Lin
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.119.226712
  • You have access
    Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation
    Robert J.H. Miller, Osamu Manabe, Balaji Tamarappoo, Sean Hayes, John D. Friedman, Piotr J. Slomka, Jignesh Patel, Jon A. Kobashigawa and Daniel S. Berman
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 249-255; DOI: https://doi.org/10.2967/jnumed.119.229625
  • You have access
    Radiomics: Data Are Also Images
    Mathieu Hatt, Catherine Cheze Le Rest, Florent Tixier, Bogdan Badic, Ulrike Schick and Dimitris Visvikis
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 38S-44S; DOI: https://doi.org/10.2967/jnumed.118.220582
  • You have access
    Machine Learning in Nuclear Medicine: Part 1—Introduction
    Carlos F. Uribe, Sulantha Mathotaarachchi, Vincent Gaudet, Kenneth C. Smith, Pedro Rosa-Neto, François Bénard, Sandra E. Black and Katherine Zukotynski
    Journal of Nuclear Medicine April 1, 2019, 60 (4) 451-458; DOI: https://doi.org/10.2967/jnumed.118.223495
  • You have access
    Nuclear Medicine and Wall Street: An Evolving Relationship
    Mike Sherman and Rachel Levine
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 20S-24S; DOI: https://doi.org/10.2967/jnumed.118.220798
  • You have access
    Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
    Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller and Richard P. Baum
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 377-385; DOI: https://doi.org/10.2967/jnumed.118.215848
  • You have access
    NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Thomas A. Hope, Amanda Abbott, Karen Colucci, David L. Bushnell, Linda Gardner, William S. Graham, Sheila Lindsay, David C. Metz, Daniel A. Pryma, Michael G. Stabin and Jonathan R. Strosberg
    Journal of Nuclear Medicine July 1, 2019, 60 (7) 937-943; DOI: https://doi.org/10.2967/jnumed.118.230607
  • You have access
    Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer
    Kelley Salem, Manoj Kumar, Yongjun Yan, Justin J. Jeffery, Kyle C. Kloepping, Ciara J. Michel, Ginny L. Powers, Aparna M. Mahajan and Amy M. Fowler
    Journal of Nuclear Medicine February 1, 2019, 60 (2) 220-226; DOI: https://doi.org/10.2967/jnumed.118.211516
  • You have access
    Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice
    Carola Focke, Tanja Blume, Benedikt Zott, Yuan Shi, Maximilian Deussing, Finn Peters, Claudio Schmidt, Gernot Kleinberger, Simon Lindner, Franz-Josef Gildehaus, Leonie Beyer, Barbara von Ungern-Sternberg, Peter Bartenstein, Laurence Ozmen, Karlheinz Baumann, Mario M. Dorostkar, Christian Haass, Helmuth Adelsberger, Jochen Herms, Axel Rominger and Matthias Brendel
    Journal of Nuclear Medicine April 1, 2019, 60 (4) 548-554; DOI: https://doi.org/10.2967/jnumed.118.217703

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire